Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery
- PMID: 23665257
- DOI: 10.1016/j.jconrel.2013.04.027
Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery
Abstract
Over the last 15 years, discovery of key growth factors and specific molecular markers for lymphatic vessels has enabled a new era of molecular research on the lymphatic vascular system. As a result, it has been found that lymphangiogenesis, the expansion of existing lymphatic vessels, plays an important role in tumor progression and in the control of chronic inflammation. At the same time, technical advancements have been made to improve the visualization of the lymphatic system. We have recently developed liposomal and polymer-based formulations of near-infrared lymphatic-specific imaging tracers for the non-invasive quantitative in vivo imaging of lymphatic vessel function. Using these tracers, a near-infrared stereomicroscope system allows imaging of initial and collecting lymphatic vessels with high spatial and temporal resolution in mice. In addition, we have developed a new method, using antibodies to a lymphatic specific marker and positron emission tomography, to sensitively detect lymphatic expansion in lymph nodes as the earliest sign of cancer metastasis. These imaging methods have great potential to provide non-invasive measures to assess the functionality of the lymphatic system and to assess the efficiency of lymphatic drug delivery.
Keywords: Cancer; Inflammation; Liposome; Lymphangiogenesis; Lymphatic vessels; Near-infrared imaging.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
In vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography.Methods Mol Biol. 2013;961:129-40. doi: 10.1007/978-1-62703-227-8_6. Methods Mol Biol. 2013. PMID: 23325639
-
Interaction of tumor cells and lymphatic vessels in cancer progression.Oncogene. 2012 Oct 18;31(42):4499-508. doi: 10.1038/onc.2011.602. Epub 2011 Dec 19. Oncogene. 2012. PMID: 22179834 Review.
-
In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.Cancer Res. 2010 Nov 1;70(21):8842-51. doi: 10.1158/0008-5472.CAN-10-0896. Epub 2010 Oct 26. Cancer Res. 2010. PMID: 20978206 Free PMC article.
-
Lymphatic vessels: new targets for the treatment of inflammatory diseases.Angiogenesis. 2014 Apr;17(2):359-71. doi: 10.1007/s10456-013-9406-1. Epub 2013 Nov 9. Angiogenesis. 2014. PMID: 24212981 Review.
-
Molecular control of lymphatic metastasis.Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Ann N Y Acad Sci. 2008. PMID: 18519975 Review.
Cited by
-
The Lymphatic Vasculature: Its Role in Adipose Metabolism and Obesity.Cell Metab. 2017 Oct 3;26(4):598-609. doi: 10.1016/j.cmet.2017.07.020. Epub 2017 Aug 24. Cell Metab. 2017. PMID: 28844882 Free PMC article. Review.
-
Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles.Int J Mol Sci. 2018 Jul 23;19(7):2138. doi: 10.3390/ijms19072138. Int J Mol Sci. 2018. PMID: 30041452 Free PMC article.
-
Protein Phosphatase 2A in Lipopolysaccharide-Induced Cyclooxygenase-2 Expression in Murine Lymphatic Endothelial Cells.PLoS One. 2015 Aug 28;10(8):e0137177. doi: 10.1371/journal.pone.0137177. eCollection 2015. PLoS One. 2015. PMID: 26317424 Free PMC article.
-
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes.Pharmacol Rev. 2024 Feb 13;76(2):228-250. doi: 10.1124/pharmrev.123.000938. Pharmacol Rev. 2024. PMID: 38351070 Review.
-
The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery.J Nanobiotechnology. 2022 Jan 6;20(1):24. doi: 10.1186/s12951-021-01232-5. J Nanobiotechnology. 2022. PMID: 34991595 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials